01 1Suven Pharmaceuticals
01 1IRON SUCROSE COMPLEX
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-11-27
Pay. Date : 2023-09-22
DMF Number : 38865
Submission : 2023-09-29
Status : Active
Type : II
20
Suven Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IRON SUCROSE COMPLEX, with a corresponding US DMF Number 38865.
Remarkably, this DMF maintains an Active status since its submission on September 29, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 27, 2023, and payment made on September 22, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
